These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 26776441

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis.
    Moore SM, Khalaj AJ, Kumar S, Winchester Z, Yoon J, Yoo T, Martinez-Torres L, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK.
    Proc Natl Acad Sci U S A; 2014 Dec 16; 111(50):18061-6. PubMed ID: 25453074
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
    Khalaj AJ, Yoon J, Nakai J, Winchester Z, Moore SM, Yoo T, Martinez-Torres L, Kumar S, Itoh N, Tiwari-Woodruff SK.
    Proc Natl Acad Sci U S A; 2013 Nov 19; 110(47):19125-30. PubMed ID: 24191028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
    Liu SQ, Zhang ML, Zhang HJ, Liu FZ, Chu RJ, Zhang GX, Zhu L.
    Life Sci; 2017 Jul 01; 180():36-41. PubMed ID: 28499934
    [Abstract] [Full Text] [Related]

  • 7. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.
    Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK.
    Brain; 2010 Oct 01; 133(10):2999-3016. PubMed ID: 20858739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J, Sikkema AH, van der Bij K, de Jonge JC, Klappe K, Nies V, Jonker JW, Kok JW, Hoekstra D, Baron W.
    J Neurosci; 2017 Oct 11; 37(41):9925-9938. PubMed ID: 28899916
    [Abstract] [Full Text] [Related]

  • 12. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J, Zhang ZG, Li Y, Lu M, Zhang Y, Elias SB, Chopp M.
    Neurobiol Dis; 2016 Apr 11; 88():85-95. PubMed ID: 26805386
    [Abstract] [Full Text] [Related]

  • 13. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R, Böttiger G, Stadelmann C, Karnati S, Berghoff M.
    Cells; 2021 Apr 13; 10(4):. PubMed ID: 33924474
    [Abstract] [Full Text] [Related]

  • 14. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
    Zhang Y, Li X, Ciric B, Curtis MT, Chen WJ, Rostami A, Zhang GX.
    Proc Natl Acad Sci U S A; 2020 Apr 21; 117(16):9082-9093. PubMed ID: 32253301
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.
    Voskuhl RR, Itoh N, Tassoni A, Matsukawa MA, Ren E, Tse V, Jang E, Suen TT, Itoh Y.
    Proc Natl Acad Sci U S A; 2019 May 14; 116(20):10130-10139. PubMed ID: 31040210
    [Abstract] [Full Text] [Related]

  • 17. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
    Xiao L, Guo D, Hu C, Shen W, Shan L, Li C, Liu X, Yang W, Zhang W, He C.
    Glia; 2012 Jul 14; 60(7):1037-52. PubMed ID: 22461009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Remyelinating strategies in multiple sclerosis.
    Luessi F, Kuhlmann T, Zipp F.
    Expert Rev Neurother; 2014 Nov 14; 14(11):1315-34. PubMed ID: 25331418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.